A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress

Sumel Ashique, Shubneesh Kumar, H. Kumar, Jayita Roy, S. Pal, Swagata Pal
{"title":"A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress","authors":"Sumel Ashique, Shubneesh Kumar, H. Kumar, Jayita Roy, S. Pal, Swagata Pal","doi":"10.4103/kleuhsj.kleuhsj_505_22","DOIUrl":null,"url":null,"abstract":"Even if many countries are against it since vaccinations are not readily available, industrialized countries continue to make some vaccines designated under the World Health Organization's emergency use listing mandatory for entry into their countries. The first half of 2021 has seen the introduction of SARS-CoV-2 vaccinations in several countries, after the exceptional speed of vaccine development and testing in 2020. Using keywords in online databases such as Pubmed, Scopus, Web of Science, Cochrane, and Embase, this systematic search was carried out. The findings were collected into a report. We were unable to do an adequate human study because we included so many different kinds of vaccinations. A look at current vaccination-controlled trials and actual facts on immunization success is also presented. The efficacy of new vaccines is continually being tested in ongoing vaccine trials. Increasing the alternatives for global vaccine production to manufacture sufficient vaccine shots for international usage and to enhance the statistics for the potential utility of various vaccination platforms in forthcoming pandemics are also a result of this.","PeriodicalId":13457,"journal":{"name":"Indian Journal of Health Sciences and Biomedical Research (KLEU)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Health Sciences and Biomedical Research (KLEU)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/kleuhsj.kleuhsj_505_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Even if many countries are against it since vaccinations are not readily available, industrialized countries continue to make some vaccines designated under the World Health Organization's emergency use listing mandatory for entry into their countries. The first half of 2021 has seen the introduction of SARS-CoV-2 vaccinations in several countries, after the exceptional speed of vaccine development and testing in 2020. Using keywords in online databases such as Pubmed, Scopus, Web of Science, Cochrane, and Embase, this systematic search was carried out. The findings were collected into a report. We were unable to do an adequate human study because we included so many different kinds of vaccinations. A look at current vaccination-controlled trials and actual facts on immunization success is also presented. The efficacy of new vaccines is continually being tested in ongoing vaccine trials. Increasing the alternatives for global vaccine production to manufacture sufficient vaccine shots for international usage and to enhance the statistics for the potential utility of various vaccination platforms in forthcoming pandemics are also a result of this.
简要概述针对ncovid - 19的各种疫苗,包括安全性、有效性、报告病例、临床试验和进展
尽管许多国家反对,因为疫苗不容易获得,但工业化国家继续强制要求世界卫生组织紧急用途清单中指定的一些疫苗进入其国家。继2020年疫苗开发和测试的异常速度之后,2021年上半年,一些国家开始接种SARS-CoV-2疫苗。利用Pubmed、Scopus、Web of Science、Cochrane、Embase等在线数据库中的关键词进行系统检索。调查结果被收集成一份报告。我们无法进行充分的人体研究因为我们纳入了太多不同种类的疫苗。还介绍了目前的疫苗控制试验和免疫成功的实际情况。正在进行的疫苗试验不断检验新疫苗的效力。增加全球疫苗生产的替代办法,以生产足够的疫苗注射供国际使用,并加强各种疫苗接种平台在即将到来的大流行病中潜在效用的统计数据,也是这样做的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
56
审稿时长
32 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信